Caitlin M. Wilmot

ID: 1b83c154-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

PTAB Denies Sandoz’s IPR Petition for Humira®-Related Patent

Biosimilars Law Bulletin · May 17, 2018

USPTO Proposes Narrower AIA Claim Construction Standard to Match District Courts

PTAB Law Blog · May 14, 2018

Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes

Biosimilars Law Bulletin · April 3, 2018

Patent Examiners Will Get a Head Start with Automated Prior Art Searches

PTAB Law Blog · March 29, 2018

Lupin’s Generic Version of Tamiflu® Joins the Band of Flu Fighters

Biosimilars Law Bulletin · February 20, 2018

Practice Areas

Health Care and Life Sciences

Intellectual Property

Jurisdictions

Washington, D.C.